Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03371225 · ClinicalTrials.gov registry record · NA
Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System
A NA study, sponsored by Spaulding Rehabilitation Hospital.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT03371225 is a NA study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 116 participants.
The verdict
NCT03371225, a NA study, has completed, sponsored by Spaulding Rehabilitation Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
This trial aims at understanding the mechanisms of optimized transcranial direct current stimulation (tDCS) (16 tDCS sessions combined with exercise)\] on pain control. Optimized tDCS can lead to stronger engagement of the endogenous pain regulatory system that will ultimately lead to increased pain relief in patients with fibromyalgia (FM). Therefore, the investigators designed a 2x2 factorial mechanistic trial \[tDCS (active and sham) and aerobic exercise (AE) (active and control)\] to evaluate the effects of 4 weeks of tDCS coupled with exercise on the endogenous pain regulatory system assessed by conditioned pain modulation (CPM) and central sensitization as assessed by temporal slow pain summation (TSPS), and compared to either intervention alone and to no intervention.
Interventions
- DEVICE Sham tDCS
- DEVICE Active tDCS
- PROCEDURE Active Exercise
- PROCEDURE Sham Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2025-10-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03371225
The ClinicalTrials.gov registry entry for NCT03371225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sham tDCS is the first listed.
NCT03371225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03371225 about?
NCT03371225 is a clinical study titled "Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System". This trial aims at understanding the mechanisms of optimized transcranial direct current stimulation (tDCS) (16 tDCS sessions combined with exercise)\] on pain control. Optimized tDCS can lead to stronger engagement of the endogenous pain regulatory system that will ultimately lead to increased pain...
What is the current status of trial NCT03371225?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2019-05-01. Estimated completion is 2025-10-26.
What interventions are being tested in trial NCT03371225?
The interventions under investigation include: Sham tDCS (DEVICE), Active tDCS (DEVICE), Active Exercise (PROCEDURE), Sham Exercise (PROCEDURE).
Who is sponsoring clinical trial NCT03371225?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.